In 2011, Accuray completed its acquisition of TomoTherapy Inc., a pioneer in advanced radiation therapy solutions for cancer care. Today, Accuray continues the legacy of innovation with a commitment to expanding the powerful potential of radiation therapy to improve as many lives as possible. Accuray invents unique, market-changing solutions such as the CyberKnife and the Radixact System, the latest generation TomoTherapy platform, that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster.
TomoTherapy raised undisclosed on December 30, 2000